Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Parkinson Disease, Secondary

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Parkinson Disease, Secondary in 3 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, S1
Zhang, QJ1
Liu, J1
Wu, ZH1
Ali, U1
Wang, Y1
Chen, L1
Gui, ZH1
Dupre, KB1
Ostock, CY1
Eskow Jaunarajs, KL1
Button, T1
Savage, LM1
Wolf, W1
Bishop, C1
Frechilla, D1
Cobreros, A1
Saldise, L1
Moratalla, R1
Insausti, R1
Luquin, M1
Del Río, J1

Other Studies

3 other studies available for 8-hydroxy-2-(di-n-propylamino)tetralin and Parkinson Disease, Secondary

ArticleYear
The firing activity of pyramidal neurons in medial prefrontal cortex and their response to 5-hydroxytryptamine-1A receptor stimulation in a rat model of Parkinson's disease.
    Neuroscience, 2009, Sep-15, Volume: 162, Issue:4

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Action Potentials; Animals; Cell Count; Male; Oxidopamine; P

2009
Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats.
    Experimental neurology, 2011, Volume: 229, Issue:2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antiparkinson Agents; Benserazide; Benzazepines; Ch

2011
Serotonin 5-HT(1A) receptor expression is selectively enhanced in the striosomal compartment of chronic parkinsonian monkeys.
    Synapse (New York, N.Y.), 2001, Mar-15, Volume: 39, Issue:4

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Autor

2001